+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Syphilis Testing Market 2024-2028

  • PDF Icon

    Report

  • 164 Pages
  • October 2023
  • Region: Global
  • TechNavio
  • ID: 4894580
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The syphilis testing market is forecasted to grow by USD 2220.61 mn during 2023-2028, accelerating at a CAGR of 6.7% during the forecast period. The report on the syphilis testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the prevalence of syphilis, a rising focus on vertical transmission prevention, and a rise in the adoption of POC testing devices.

The syphilis testing market is segmented as below:

By End-user

  • Primary and secondary syphilis
  • Latent
  • tertiary syphilis

By Technology

  • Laboratory testing/conventional testing
  • POC testing

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advancements in syphilis testing technologies as one of the prime reasons driving the syphilis testing market growth during the next few years. Also, technological innovations in home-based testing and expansion of diagnostic laboratory industry will lead to sizable demand in the market.

The report on the syphilis testing market covers the following areas:

  • Syphilis testing market sizing
  • Syphilis testing market forecast
  • Syphilis testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading syphilis testing market vendors that include Abbott Laboratories, AdvaCare Pharma, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioLytical Laboratories Inc., Bloodworks Northwest, Calibre Scientific Inc., Danaher Corp., DiaSorin SpA, Everlywell Inc., F. Hoffmann La Roche Ltd., Hologic Inc., LetsGetChecked, Meril Life Sciences Pvt. Ltd., OK Biotech Co. Ltd., Omega Diagnostics Group Plc, OriGene Technologies Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc.. Also, the syphilis testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global syphilis testing market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global syphilis testing market 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Technology Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Primary and secondary syphilis - Market size and forecast 2023-2028
Exhibit 34: Chart on Primary and secondary syphilis - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Primary and secondary syphilis - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Primary and secondary syphilis - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Primary and secondary syphilis - Year-over-year growth 2023-2028 (%)
6.4 Latent and tertiary syphilis - Market size and forecast 2023-2028
Exhibit 38: Chart on Latent and tertiary syphilis - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Latent and tertiary syphilis - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Latent and tertiary syphilis - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Latent and tertiary syphilis - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
Exhibit 42: Market opportunity by End-user ($ million)
Exhibit 43: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Technology
7.1 Market segments
Exhibit 44: Chart on Technology - Market share 2023-2028 (%)
Exhibit 45: Data Table on Technology - Market share 2023-2028 (%)
7.2 Comparison by Technology
Exhibit 46: Chart on Comparison by Technology
Exhibit 47: Data Table on Comparison by Technology
7.3 Laboratory testing/conventional testing - Market size and forecast 2023-2028
Exhibit 48: Chart on Laboratory testing/conventional testing - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Laboratory testing/conventional testing - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Laboratory testing/conventional testing - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Laboratory testing/conventional testing - Year-over-year growth 2023-2028 (%)
7.4 POC testing - Market size and forecast 2023-2028
Exhibit 52: Chart on POC testing - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on POC testing - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on POC testing - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on POC testing - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Technology
Exhibit 56: Market opportunity by Technology ($ million)
Exhibit 57: Data Table on Market opportunity by Technology ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 Beckman Coulter Inc.
Exhibit 112: Beckman Coulter Inc. - Overview
Exhibit 113: Beckman Coulter Inc. - Product/Service
Exhibit 114: Beckman Coulter Inc. - Key offerings
12.5 Becton Dickinson and Co.
Exhibit 115: Becton Dickinson and Co. - Overview
Exhibit 116: Becton Dickinson and Co. - Business segments
Exhibit 117: Becton Dickinson and Co. - Key news
Exhibit 118: Becton Dickinson and Co. - Key offerings
Exhibit 119: Becton Dickinson and Co. - Segment focus
12.6 Bio Rad Laboratories Inc.
Exhibit 120: Bio Rad Laboratories Inc. - Overview
Exhibit 121: Bio Rad Laboratories Inc. - Business segments
Exhibit 122: Bio Rad Laboratories Inc. - Key news
Exhibit 123: Bio Rad Laboratories Inc. - Key offerings
Exhibit 124: Bio Rad Laboratories Inc. - Segment focus
12.7 bioLytical Laboratories Inc.
Exhibit 125: bioLytical Laboratories Inc. - Overview
Exhibit 126: bioLytical Laboratories Inc. - Product/Service
Exhibit 127: bioLytical Laboratories Inc. - Key offerings
12.8 Bloodworks Northwest
Exhibit 128: Bloodworks Northwest - Overview
Exhibit 129: Bloodworks Northwest - Business segments
Exhibit 130: Bloodworks Northwest - Key offerings
Exhibit 131: Bloodworks Northwest - Segment focus
12.9 Danaher Corp.
Exhibit 132: Danaher Corp. - Overview
Exhibit 133: Danaher Corp. - Business segments
Exhibit 134: Danaher Corp. - Key news
Exhibit 135: Danaher Corp. - Key offerings
Exhibit 136: Danaher Corp. - Segment focus
12.10 DiaSorin SpA
Exhibit 137: DiaSorin SpA - Overview
Exhibit 138: DiaSorin SpA - Business segments
Exhibit 139: DiaSorin SpA - Key news
Exhibit 140: DiaSorin SpA - Key offerings
Exhibit 141: DiaSorin SpA - Segment focus
12.11 F. Hoffmann La Roche Ltd.
Exhibit 142: F. Hoffmann La Roche Ltd. - Overview
Exhibit 143: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 144: F. Hoffmann La Roche Ltd. - Key news
Exhibit 145: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 146: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Hologic Inc.
Exhibit 147: Hologic Inc. - Overview
Exhibit 148: Hologic Inc. - Business segments
Exhibit 149: Hologic Inc. - Key news
Exhibit 150: Hologic Inc. - Key offerings
Exhibit 151: Hologic Inc. - Segment focus
12.13 Meril Life Sciences Pvt. Ltd.
Exhibit 152: Meril Life Sciences Pvt. Ltd. - Overview
Exhibit 153: Meril Life Sciences Pvt. Ltd. - Product/Service
Exhibit 154: Meril Life Sciences Pvt. Ltd. - Key offerings
12.14 Omega Diagnostics Group Plc
Exhibit 155: Omega Diagnostics Group Plc - Overview
Exhibit 156: Omega Diagnostics Group Plc - Product/Service
Exhibit 157: Omega Diagnostics Group Plc - Key offerings
12.15 OriGene Technologies Inc.
Exhibit 158: OriGene Technologies Inc. - Overview
Exhibit 159: OriGene Technologies Inc. - Product/Service
Exhibit 160: OriGene Technologies Inc. - Key offerings
12.16 Siemens Healthineers AG
Exhibit 161: Siemens Healthineers AG - Overview
Exhibit 162: Siemens Healthineers AG - Business segments
Exhibit 163: Siemens Healthineers AG - Key news
Exhibit 164: Siemens Healthineers AG - Key offerings
Exhibit 165: Siemens Healthineers AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 166: Thermo Fisher Scientific Inc. - Overview
Exhibit 167: Thermo Fisher Scientific Inc. - Business segments
Exhibit 168: Thermo Fisher Scientific Inc. - Key news
Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global syphilis testing market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Primary and secondary syphilis - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Primary and secondary syphilis - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Primary and secondary syphilis - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Primary and secondary syphilis - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Latent and tertiary syphilis - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Latent and tertiary syphilis - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Latent and tertiary syphilis - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Latent and tertiary syphilis - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by End-user ($ million)
Exhibits 43: Data Table on Market opportunity by End-user ($ million)
Exhibits 44: Chart on Technology - Market share 2023-2028 (%)
Exhibits 45: Data Table on Technology - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by Technology
Exhibits 47: Data Table on Comparison by Technology
Exhibits 48: Chart on Laboratory testing/conventional testing - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Laboratory testing/conventional testing - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Laboratory testing/conventional testing - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Laboratory testing/conventional testing - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on POC testing - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on POC testing - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on POC testing - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on POC testing - Year-over-year growth 2023-2028 (%)
Exhibits 56: Market opportunity by Technology ($ million)
Exhibits 57: Data Table on Market opportunity by Technology ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ million)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 101: Impact of drivers and challenges in 2023 and 2028
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Abbott Laboratories - Overview
Exhibits 108: Abbott Laboratories - Business segments
Exhibits 109: Abbott Laboratories - Key news
Exhibits 110: Abbott Laboratories - Key offerings
Exhibits 111: Abbott Laboratories - Segment focus
Exhibits 112: Beckman Coulter Inc. - Overview
Exhibits 113: Beckman Coulter Inc. - Product/Service
Exhibits 114: Beckman Coulter Inc. - Key offerings
Exhibits 115: Becton Dickinson and Co. - Overview
Exhibits 116: Becton Dickinson and Co. - Business segments
Exhibits 117: Becton Dickinson and Co. - Key news
Exhibits 118: Becton Dickinson and Co. - Key offerings
Exhibits 119: Becton Dickinson and Co. - Segment focus
Exhibits 120: Bio Rad Laboratories Inc. - Overview
Exhibits 121: Bio Rad Laboratories Inc. - Business segments
Exhibits 122: Bio Rad Laboratories Inc. - Key news
Exhibits 123: Bio Rad Laboratories Inc. - Key offerings
Exhibits 124: Bio Rad Laboratories Inc. - Segment focus
Exhibits 125: bioLytical Laboratories Inc. - Overview
Exhibits 126: bioLytical Laboratories Inc. - Product/Service
Exhibits 127: bioLytical Laboratories Inc. - Key offerings
Exhibits 128: Bloodworks Northwest - Overview
Exhibits 129: Bloodworks Northwest - Business segments
Exhibits 130: Bloodworks Northwest - Key offerings
Exhibits 131: Bloodworks Northwest - Segment focus
Exhibits 132: Danaher Corp. - Overview
Exhibits 133: Danaher Corp. - Business segments
Exhibits 134: Danaher Corp. - Key news
Exhibits 135: Danaher Corp. - Key offerings
Exhibits 136: Danaher Corp. - Segment focus
Exhibits 137: DiaSorin SpA - Overview
Exhibits 138: DiaSorin SpA - Business segments
Exhibits 139: DiaSorin SpA - Key news
Exhibits 140: DiaSorin SpA - Key offerings
Exhibits 141: DiaSorin SpA - Segment focus
Exhibits 142: F. Hoffmann La Roche Ltd. - Overview
Exhibits 143: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 144: F. Hoffmann La Roche Ltd. - Key news
Exhibits 145: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 146: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 147: Hologic Inc. - Overview
Exhibits 148: Hologic Inc. - Business segments
Exhibits 149: Hologic Inc. - Key news
Exhibits 150: Hologic Inc. - Key offerings
Exhibits 151: Hologic Inc. - Segment focus
Exhibits 152: Meril Life Sciences Pvt. Ltd. - Overview
Exhibits 153: Meril Life Sciences Pvt. Ltd. - Product/Service
Exhibits 154: Meril Life Sciences Pvt. Ltd. - Key offerings
Exhibits 155: Omega Diagnostics Group Plc - Overview
Exhibits 156: Omega Diagnostics Group Plc - Product/Service
Exhibits 157: Omega Diagnostics Group Plc - Key offerings
Exhibits 158: OriGene Technologies Inc. - Overview
Exhibits 159: OriGene Technologies Inc. - Product/Service
Exhibits 160: OriGene Technologies Inc. - Key offerings
Exhibits 161: Siemens Healthineers AG - Overview
Exhibits 162: Siemens Healthineers AG - Business segments
Exhibits 163: Siemens Healthineers AG - Key news
Exhibits 164: Siemens Healthineers AG - Key offerings
Exhibits 165: Siemens Healthineers AG - Segment focus
Exhibits 166: Thermo Fisher Scientific Inc. - Overview
Exhibits 167: Thermo Fisher Scientific Inc. - Business segments
Exhibits 168: Thermo Fisher Scientific Inc. - Key news
Exhibits 169: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 170: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 171: Inclusions checklist
Exhibits 172: Exclusions checklist
Exhibits 173: Currency conversion rates for US$
Exhibits 174: Research methodology
Exhibits 175: Validation techniques employed for market sizing
Exhibits 176: Information sources
Exhibits 177: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global syphilis testing market: Abbott Laboratories, AdvaCare Pharma, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioLytical Laboratories Inc., Bloodworks Northwest, Calibre Scientific Inc., Danaher Corp., DiaSorin SpA, Everlywell Inc., F. Hoffmann La Roche Ltd., Hologic Inc., LetsGetChecked, Meril Life Sciences Pvt. Ltd., OK Biotech Co. Ltd., Omega Diagnostics Group Plc, OriGene Technologies Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advancements in syphilis testing technologies.'

According to the report, one of the major drivers for this market is the increase in prevalence of syphilis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AdvaCare Pharma
  • Beckman Coulter Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioLytical Laboratories Inc.
  • Bloodworks Northwest
  • Calibre Scientific Inc.
  • Danaher Corp.
  • DiaSorin SpA
  • Everlywell Inc.
  • F. Hoffmann La Roche Ltd.
  • Hologic Inc.
  • LetsGetChecked
  • Meril Life Sciences Pvt. Ltd.
  • OK Biotech Co. Ltd.
  • Omega Diagnostics Group Plc
  • OriGene Technologies Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Syphilis Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Syphilis Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From
Syphilis Testing Market by Type, Location of Testing, and Region 2024-2032 - Product Image

Syphilis Testing Market by Type, Location of Testing, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
2024-2028 Global Syphilis Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Syphilis Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2024-2028 - Product Image

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2024-2028

  • Report
  • 164 Pages
  • Global
From
Pneumonia Testing Market 2024-2028 - Product Image

Pneumonia Testing Market 2024-2028

  • Report
  • 178 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.